Bambusa Therapeutics, Inc. — Form D
Bambusa Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-08. The offering totals $5.1M, of which $5.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-01-08
- Form: D
- Accession: 0002044950-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.1M
- Amount sold: $5.1M
- Investors: 4
- Date of first sale: 2024-06-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-534581
Issuer
- Name: Bambusa Therapeutics, Inc.
- CIK: 0002044950
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: ONE MARINA PARK DRIVE, SUITE 1410, BOSTON, MA, 02210
- Phone: 949-887-7927
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Sean Marett | Director | Boston, MA |
| Helmut Jeggle | Director | Boston, MA |
| Derek DiRocco | Director | Boston, MA |
| Shanshan Xu | Director | Boston, MA |
| Shanshan Xu | Executive Officer | Boston, MA |
| Shanshan Xu | Promoter | Boston, MA |
Other filings by this issuer (2)
More